ASX - By Stock
|
CMP |
Re:
Ann: Corporate Presentation
|
|
willxue123
|
16 |
9.4K |
0 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
16
|
9.4K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
The China conection
|
|
willxue123
|
15 |
5.6K |
0 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
15
|
5.6K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: S&P DJI Announces March 2021 Quarterly Rebalance
|
|
willxue123
|
1 |
1.0K |
0 |
12/03/21 |
12/03/21 |
ASX - By Stock
|
1
|
1.0K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Czech Republic Grants National Authorisation for TLX591 Kit
|
|
willxue123
|
3 |
2.0K |
2 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
3
|
2.0K
|
2
|
|
ASX - By Stock
|
DMC |
Re:
Ann: Q2 Business Update and Appendix 4C
|
|
willxue123
|
32 |
10K |
2 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
32
|
10K
|
2
|
|
ASX - By Stock
|
DMC |
Re:
Ann: CEO Address at Extraordinary General Meeting
|
|
willxue123
|
3 |
1.1K |
0 |
12/02/21 |
12/02/21 |
ASX - By Stock
|
3
|
1.1K
|
0
|
|
ASX - By Stock
|
DMC |
Re:
Ann: Q2 Business Update and Appendix 4C
|
|
willxue123
|
32 |
10K |
0 |
08/02/21 |
08/02/21 |
ASX - By Stock
|
32
|
10K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Telix and ASX200 and $1 billion market cap
|
|
willxue123
|
67 |
36K |
6 |
01/02/21 |
01/02/21 |
ASX - By Stock
|
67
|
36K
|
6
|
|
ASX - By Stock
|
LVT |
Re:
23 months invested loss = 23%
|
|
willxue123
|
69 |
27K |
0 |
26/01/21 |
26/01/21 |
ASX - By Stock
|
69
|
27K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Telix and ASX200 and $1 billion market cap
|
|
willxue123
|
67 |
36K |
3 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
67
|
36K
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
PIQ Mkt Cap vs RHY vs RENX/RNLX
|
|
willxue123
|
70 |
21K |
1 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
70
|
21K
|
1
|
|
ASX - By Stock
|
RGI |
Re:
Can you feel it.
|
|
willxue123
|
740 |
322K |
0 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
740
|
322K
|
0
|
|
ASX - By Stock
|
EMD |
Re:
Ann: Trading Halt
|
|
willxue123
|
4 |
1.4K |
1 |
14/12/20 |
14/12/20 |
ASX - By Stock
|
4
|
1.4K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Release of shares from voluntary escrow
|
|
willxue123
|
2 |
1.8K |
3 |
11/12/20 |
11/12/20 |
ASX - By Stock
|
2
|
1.8K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: TGA Priority Review Granted for Prostate Cancer Imaging
|
|
willxue123
|
5 |
2.9K |
0 |
07/12/20 |
07/12/20 |
ASX - By Stock
|
5
|
2.9K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
PIQ Mkt Cap vs RHY vs RENX/RNLX
|
|
willxue123
|
70 |
21K |
8 |
03/12/20 |
03/12/20 |
ASX - By Stock
|
70
|
21K
|
8
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Overview of ProstACT Phase III Study - Investor supplement
|
|
willxue123
|
18 |
6.7K |
6 |
03/12/20 |
03/12/20 |
ASX - By Stock
|
18
|
6.7K
|
6
|
|
ASX - By Stock
|
360 |
Re:
$4.79 Party
|
|
willxue123
|
54 |
20K |
3 |
25/11/20 |
25/11/20 |
ASX - By Stock
|
54
|
20K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: NDA for Prostate Cancer Imaging accepted by US FDA
|
|
willxue123
|
21 |
7.2K |
1 |
25/11/20 |
25/11/20 |
ASX - By Stock
|
21
|
7.2K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Becoming a substantial holder
|
|
willxue123
|
14 |
4.3K |
0 |
10/11/20 |
10/11/20 |
ASX - By Stock
|
14
|
4.3K
|
0
|
|
ASX - By Stock
|
360 |
Re:
There is a big problem with the company's products
|
|
willxue123
|
7 |
1.8K |
2 |
08/11/20 |
08/11/20 |
ASX - By Stock
|
7
|
1.8K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Investor Briefing - Asia Strategy
|
|
willxue123
|
40 |
15K |
7 |
05/11/20 |
05/11/20 |
ASX - By Stock
|
40
|
15K
|
7
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Investor Briefing - Asia Strategy
|
|
willxue123
|
40 |
15K |
2 |
03/11/20 |
03/11/20 |
ASX - By Stock
|
40
|
15K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
China Grand Pharmaceutical to Acquire 7.6% Stake in Telix
|
|
willxue123
|
17 |
7.6K |
4 |
02/11/20 |
02/11/20 |
ASX - By Stock
|
17
|
7.6K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
China Grand Pharmaceutical to Acquire 7.6% Stake in Telix
|
|
willxue123
|
17 |
7.6K |
2 |
02/11/20 |
02/11/20 |
ASX - By Stock
|
17
|
7.6K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Trading Halt
|
|
willxue123
|
19 |
6.8K |
1 |
30/10/20 |
30/10/20 |
ASX - By Stock
|
19
|
6.8K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Licence Agmt with DKFZ for Image-Guided Prostate Surgery
|
|
willxue123
|
2 |
770 |
1 |
28/10/20 |
28/10/20 |
ASX - By Stock
|
2
|
770
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
willxue123
|
18 |
4.8K |
1 |
27/10/20 |
27/10/20 |
ASX - By Stock
|
18
|
4.8K
|
1
|
|
ASX - By Stock
|
LVT |
Re:
Ann: Company Update
|
|
willxue123
|
101 |
32K |
0 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
101
|
32K
|
0
|
|
ASX - By Stock
|
VHT |
Re:
Ann: Q2 Business Update
|
|
willxue123
|
119 |
46K |
1 |
08/10/20 |
08/10/20 |
ASX - By Stock
|
119
|
46K
|
1
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: Micro-X Market update - First Sale of Rover
|
|
willxue123
|
22 |
11K |
4 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
22
|
11K
|
4
|
|
ASX - By Stock
|
IME |
Re:
Ann: Consolidation/Split - IME
|
|
willxue123
|
30 |
8.7K |
0 |
29/09/20 |
29/09/20 |
ASX - By Stock
|
30
|
8.7K
|
0
|
|
ASX - By Stock
|
PET |
Re:
KPMG investigates Phoslock's accounts -AFR
|
|
willxue123
|
2 |
1.1K |
1 |
22/09/20 |
22/09/20 |
ASX - By Stock
|
2
|
1.1K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Strategic Collaboration with Varian for Prostate Imaging
|
|
willxue123
|
26 |
8.3K |
1 |
03/09/20 |
03/09/20 |
ASX - By Stock
|
26
|
8.3K
|
1
|
|
ASX - By Stock
|
EML |
Re:
EML is not a BNPL stock
|
|
willxue123
|
303 |
110K |
7 |
01/09/20 |
01/09/20 |
ASX - By Stock
|
303
|
110K
|
7
|
|
ASX - By Stock
|
TLX |
Re:
Ann: FDA grants orphan drug designation for TLX102
|
|
willxue123
|
5 |
2.2K |
0 |
31/08/20 |
31/08/20 |
ASX - By Stock
|
5
|
2.2K
|
0
|
|
ASX - By Stock
|
ATG |
Re:
Ann: Becoming a substantial holder
|
|
willxue123
|
9 |
2.3K |
0 |
27/08/20 |
27/08/20 |
ASX - By Stock
|
9
|
2.3K
|
0
|
|
ASX - By Stock
|
VR1 |
Re:
Facebook focussing on AR and VR
|
|
willxue123
|
11 |
3.0K |
1 |
26/08/20 |
26/08/20 |
ASX - By Stock
|
11
|
3.0K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Half Year Shareholder Update
|
|
willxue123
|
9 |
4.4K |
1 |
25/08/20 |
25/08/20 |
ASX - By Stock
|
9
|
4.4K
|
1
|
|
ASX - By Stock
|
EVS |
Re:
Ann: Sales update
|
|
willxue123
|
47 |
16K |
2 |
23/08/20 |
23/08/20 |
ASX - By Stock
|
47
|
16K
|
2
|
|
ASX - By Stock
|
ID8 |
Re:
Ann: Becoming a substantial holder
|
|
willxue123
|
14 |
6.2K |
2 |
17/08/20 |
17/08/20 |
ASX - By Stock
|
14
|
6.2K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: SleepCheck Now Available in 36 Countries
|
|
willxue123
|
263 |
105K |
1 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
263
|
105K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
News: TLX Telix Pharmaceuticals Does Not See Need For More Public Market Capital During Remainder...
|
|
willxue123
|
7 |
3.6K |
1 |
07/08/20 |
07/08/20 |
ASX - By Stock
|
7
|
3.6K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
willxue123
|
5.4K |
2.7M |
0 |
22/07/20 |
22/07/20 |
ASX - By Stock
|
5.4K
|
2.7M
|
0
|
|
ASX - By Stock
|
EYE |
Re:
News: ELX Lumibird Aims To Aquire Ellex’S Laser And Ultrasound Business By Mid-2020
|
|
willxue123
|
18 |
8.8K |
0 |
01/06/20 |
01/06/20 |
ASX - By Stock
|
18
|
8.8K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
willxue123
|
17K |
6.7M |
15 |
17/05/20 |
17/05/20 |
ASX - By Stock
|
17K
|
6.7M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
willxue123
|
933 |
436K |
1 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
933
|
436K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: US NIH Trials Network to Conduct COVID-19 Phase 2/3 Trial
|
|
willxue123
|
276 |
141K |
0 |
19/04/20 |
19/04/20 |
ASX - By Stock
|
276
|
141K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Inflammatory Lung Disease Outcomes For Presentation at ISCT
|
|
willxue123
|
75 |
35K |
4 |
17/04/20 |
17/04/20 |
ASX - By Stock
|
75
|
35K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
willxue123
|
17K |
6.7M |
0 |
04/04/20 |
04/04/20 |
ASX - By Stock
|
17K
|
6.7M
|
0
|
|